Garry Pairaudeau
Chief Tech/Sci/R&D Officer bij Exscientia AI Ltd.
Profiel
Garry Pairaudeau is currently the Chief Technology Officer at Exscientia AI Ltd.
He previously worked at AstraZeneca PLC as the Head-Hit Discovery from 2017 to 2020.
He also worked as the Chief Technology Officer at Exscientia Plc from 2020 to 2023.
Dr. Pairaudeau received his undergraduate and doctorate degrees from The University of Southampton.
Actieve functies van Garry Pairaudeau
| Bedrijven | Functie | Begin |
|---|---|---|
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Chief Tech/Sci/R&D Officer | 01-11-2020 |
Eerdere bekende functies van Garry Pairaudeau
| Bedrijven | Functie | Einde |
|---|---|---|
| EXSCIENTIA PLC | Chief Tech/Sci/R&D Officer | 30-06-2023 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01-11-2020 |
Opleiding van Garry Pairaudeau
| The University of Southampton | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| EXSCIENTIA PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Health Technology |
